Rainbow Childrens Medicare (RAINBOW)₹1,275+0.38%Hospital
In the Jun 2026 quarter (consolidated), Rainbow Childrens Medicare reported sales of ₹471 Cr, up 33.1% from Jun 2025, and net profit of ₹62.92 Cr, up 16.6% year on year. For the year to Mar 2026, sales were ₹1,709 Cr and net profit ₹282 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 334 | 337 | 342 | 331 | 419 | 399 | 371 | 354 | 447 | 447 | 462 | 471 |
| Expenses | 216 | 219 | 237 | 237 | 271 | 265 | 256 | 250 | 297 | 299 | 316 | 336 |
| Operating Profit | 118 | 118 | 106 | 93.83 | 147 | 134 | 115 | 104 | 149 | 147 | 145 | 135 |
| OPM % | 34.9% | 34.9% | 30.9% | 27.9% | 34.9% | 33.9% | 30.9% | 28.9% | 32.9% | 32.9% | 30.9% | 28.9% |
| Other Income | 7.99 | 8.99 | 12.99 | 11.99 | 10.98 | 12.98 | 14.98 | 19.98 | 7.99 | 10.99 | 3.99 | 12.98 |
| Interest | 13.04 | 14.02 | 17.03 | 18.03 | 18.03 | 18.05 | 18.05 | 18.03 | 19.04 | 20.06 | 20.05 | 21.05 |
| Depreciation | 27.02 | 28.06 | 32.04 | 34.04 | 35.06 | 35.07 | 34.04 | 34.05 | 36.06 | 40.03 | 41.07 | 42.03 |
| Profit before tax | 84.75 | 84.72 | 68.81 | 52.88 | 105 | 93.82 | 76.82 | 70.83 | 102 | 97.77 | 86.71 | 83.73 |
| Tax % | 26.0% | 26.0% | 26.0% | 26.0% | 25.0% | 27.0% | 27.0% | 25.0% | 26.0% | 24.0% | 10.0% | 26.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −1.01 | 0.00 |
| Net Profit | 63.01 | 62.97 | 51.01 | 39.98 | 78.99 | 69.01 | 56.99 | 53.95 | 75.90 | 73.91 | 77.92 | 62.92 |
| EPS (Rs) | 6.19 | 6.11 | 5.01 | 3.88 | 7.75 | 6.75 | 5.54 | 5.26 | 7.40 | 7.13 | 7.58 | 5.95 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 235 | 322 | 403 | 545 | 722 | 653 | 978 | 1,179 | 1,302 | 1,521 | 1,709 | 1,827 |
| Expenses | 204 | 267 | 333 | 392 | 521 | 486 | 668 | 776 | 867 | 1,025 | 1,159 | 1,248 |
| Operating Profit | 29.95 | 54.94 | 68.96 | 151 | 201 | 165 | 307 | 399 | 431 | 493 | 547 | 575 |
| OPM % | 12.9% | 16.9% | 16.9% | 27.9% | 27.9% | 24.9% | 31.9% | 33.9% | 32.9% | 32.9% | 31.9% | 31.5% |
| Other Income | 15.97 | 10.98 | 9.98 | 7.99 | 9.99 | 9.98 | 18.99 | 30.97 | 36.97 | 50.92 | 41.95 | 35.95 |
| Interest | 3.01 | 3.01 | 4.01 | 42.11 | 48.11 | 46.09 | 56.11 | 58.15 | 63.10 | 77.23 | 82.22 | 80.20 |
| Depreciation | 18.04 | 22.02 | 28.03 | 60.04 | 69.08 | 73.12 | 83.13 | 90.16 | 112 | 138 | 151 | 159 |
| Profit before tax | 23.92 | 40.91 | 46.90 | 57.84 | 92.76 | 55.88 | 187 | 281 | 294 | 329 | 357 | 370 |
| Tax % | 28.0% | 24.0% | 22.0% | 22.0% | 41.0% | 29.0% | 26.0% | 25.0% | 26.0% | 26.0% | 21.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.01 | 6.01 | 31.03 | −1.01 |
| Net Profit | 16.99 | 30.97 | 35.99 | 44.99 | 54.99 | 39.95 | 139 | 212 | 218 | 244 | 282 | 291 |
| EPS (Rs) | 18.19 | 33.75 | 8.24 | 10.13 | 12.67 | 9.09 | 14.69 | 20.75 | 21.36 | 23.94 | 27.38 | 28.06 |
| Dividend payout % | 10.9% | 7.0% | 11.9% | 9.9% | 16.0% | 0.0% | 14.0% | 13.9% | 14.0% | 12.9% | 12.9% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.97 | 8.98 | 8.98 | 43.88 | 43.83 | 43.84 | 43.85 | 93.68 | 102 | 102 | 102 | 102 |
| Reserves | 166 | 275 | 308 | 307 | 316 | 350 | 390 | 498 | 958 | 1,157 | 1,366 | 1,546 |
| Borrowings | 22.01 | 24.00 | 26.02 | 24.01 | 475 | 500 | 528 | 591 | 570 | 765 | 763 | 890 |
| Other Liabilities | 33.84 | 40.81 | 54.74 | 72.64 | 88.57 | 122 | 115 | 111 | 139 | 145 | 144 | 235 |
| Total Liabilities | 231 | 349 | 399 | 448 | 924 | 1,017 | 1,079 | 1,294 | 1,770 | 2,169 | 2,375 | 2,772 |
| Fixed Assets | 77.69 | 123 | 174 | 295 | 699 | 699 | 769 | 855 | 928 | 1,249 | 1,393 | 1,750 |
| CWIP | 35.08 | 31.07 | 7.02 | 12.03 | 23.04 | 43.08 | 29.07 | 6.01 | 23.06 | 20.04 | 28.07 | 79.16 |
| Investments | 7.01 | 2.01 | 6.01 | 0.00 | 3.01 | 10.02 | 18.05 | 22.07 | 58.15 | 309 | 572 | 405 |
| Other Assets | 111 | 194 | 213 | 141 | 200 | 266 | 263 | 410 | 761 | 592 | 381 | 537 |
| Inventories | 3.01 | 4.01 | 7.02 | 6.02 | 7.02 | 16.04 | 10.02 | 15.04 | 19.04 | 24.04 | 28.07 | 42.08 |
| Trade receivables | 5.01 | 6.02 | 14.04 | 15.03 | 35.06 | 44.12 | 44.13 | 40.13 | 51.14 | 70.15 | 77.22 | 103 |
| Cash & equivalents | 71.24 | 151 | 88.31 | 36.12 | 77.28 | 97.43 | 95.37 | 186 | 47.17 | 10.03 | 20.08 | 34.15 |
| Total Assets | 231 | 349 | 399 | 448 | 924 | 1,017 | 1,079 | 1,294 | 1,770 | 2,169 | 2,375 | 2,772 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 26.08 | 17.06 | 36.13 | 48.12 | 127 | 170 | 143 | 225 | 330 | 322 | 397 | 421 |
| Cash from investing activity | −20.02 | −107 | −33.06 | −42.04 | −117 | −117 | −83.13 | −175 | −466 | −226 | −268 | −260 |
| Cash from financing activity | −6.98 | 92.77 | −0.99 | −6.98 | −8.97 | −51.85 | −60.79 | −43.87 | 143 | −102 | −118 | −147 |
| Net cash flow | −1.01 | 3.01 | 1.01 | −2.01 | 2.01 | 2.01 | −1.01 | 4.01 | 7.02 | −7.02 | 10.02 | 14.04 |
| Capex | 61.12 | 64.14 | 56.16 | 151 | 87.22 | 75.13 | 76.22 | 62.18 | 141 | 355 | 146 | 217 |
| Free cash flow | −34.98 | −46.01 | −20.99 | −103 | 41.99 | 96.01 | 67.04 | 162 | 188 | −31.99 | 250 | 204 |
| CFO / OP % | 95.0% | 88.0% | 79.0% | 88.0% | 94.0% | 95.0% | 102.0% | 93.0% | 103.0% | 95.0% | 97.0% | 95.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 11 | 10 | 16 | 14 | 24 | 22 | 25 | 15 | 16 | 20 | 19 | 22 |
| Inventory days | 40 | 36 | 49 | 37 | 33 | 56 | 37 | 29 | 44 | 54 | 53 | 68 |
| Days payable | 122 | 108 | 143 | 152 | 198 | 203 | 191 | 122 | 183 | 181 | 171 | 163 |
| Cash conversion cycle | −72 | −62 | −79 | −100 | −141 | −124 | −130 | −78 | −123 | −107 | −100 | −73 |
| Working capital days | −34 | −35 | −27 | −30 | −25 | −17 | −16 | −15 | 74 | 44 | 20 | 9 |
| ROCE % | 22.1% | 11.0% | 14.1% | 14.0% | 16.1% | 16.1% | 11.0% | 23.0% | 24.0% | 19.0% | 19.0% | 17.0% |
For the Jun 2026 quarter, Rainbow Childrens Medicare reported sales of ₹471 Cr, up 33.1% year on year and net profit of ₹62.92 Cr, up 16.6% year on year. The operating margin was 28.9%.
Rainbow Childrens Medicare's sales for the year to Mar 2026 were ₹1,709 Cr; over the last twelve months they were ₹1,827 Cr.
Net profit for the year to Mar 2026 was ₹282 Cr, and ₹291 Cr over the last twelve months. Earnings per share over the same trailing period were ₹28.06.
Rainbow Childrens Medicare reported borrowings of ₹890 Cr at Mar 2026, against cash and equivalents of ₹34.15 Cr.
Cash from operations was ₹421 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹204 Cr.